The Immunosuppressant FK-506 Specifically Inhibits Mitogen- Induced Activation of the Interleukin-2 Promoter and the Isolated Enhancer Elements NFIL-2A and NF-AT1

REFERENCES

• Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rhamsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. IΚB: a specific inhibitor of NF-ΚB transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Banerji, S. Unpublished observation.
   Google Scholar
• Banerji, S., A. Siddiqui, D. Mark, and M. Tocci. Unpublished data.
   Google Scholar
• Bierer, B. E., P. S. Mattila, R. F. Staandaert, L. A. Herzenberg, S. J. Burakoff, G. Crabtree, and S. L. Schreiber. 1990. Two distinct single transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK-506 or rapamycin. Proc. Natl. Acad. Sci. USA 87:9231–9235.
   PubMed Web of Science ®Google Scholar
• Bohnlein, E., D. W. Ballard, H. Bogerd, N. J. Peffer, J. W. Lowenthal, and W. C. Greene. 1989. Induction of interleukin-2 receptor α gene expression is regulated by post-translational activation of ΚB specific DNA binding proteins. J. Biol. Chem. 264:8475–8478.
   PubMedGoogle Scholar
• Brunvand, M. W., A. Schmidt, and U. Siebenlist. 1988. Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene. J. Biol. Chem. 263:18904–18910.
   PubMedGoogle Scholar
• Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355–361.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dumont, F. J., M. R. Melino, M. J. Staruch, S. L. Koprak, P. A. Fischer, and N. H. Sigal. 1990. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J. Immunol. 144:1418–1424.
   PubMed Web of Science ®Google Scholar
• Dumont, F. J., M. J. Strauch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144:251–258.
   PubMed Web of Science ®Google Scholar
• Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 5′ end of the interleukin-2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395–407.
   PubMed Web of Science ®Google Scholar
• Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715–1724.
   PubMed Web of Science ®Google Scholar
• Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T-cell activation. Science 246:1617–1620.
   PubMed Web of Science ®Google Scholar
• Fischer, G., L. B. Wittman, K. Lang, T. Kiefhaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (London) 337:476-478.
   PubMed Web of Science ®Google Scholar
• Frantz, B., E. Nordby, M. Tocci, and E. A. O’Neill. Submitted for publication.
   Google Scholar
• Fried, M. G., and D. M. Crothers. 1981. Equilibria and kinetics for LAC-repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505–6520.
   PubMed Web of Science ®Google Scholar
• Fromental, C., M. Kanno, H. Nomiyama, and P. Chambon. 1988. Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell 54:943–953.
   PubMedGoogle Scholar
• Fujita, T., H. Shibuya, T. Ohashi, K. Yamanishi, and T. Taniguchi. 1986. Regulation of the human IL-2 gene: functional DNA sequences in the 5′-flanking region for gene expression in activated T-lymphocytes. Cell 46:401–405.
   PubMedGoogle Scholar
• Gerster, T., and R. G. Roeder. 1988. A herpesvirus transactivating protein interacts with transcription factor OTF-1 and other cellular proteins. Proc. Natl. Acad. Sci. USA 85:6347–6351.
   PubMedGoogle Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Granelli-Piperino, A., L. Andrus, and R. M. Steinman. 1986. Lymphokine and non-lymphokine mRNA levels in stimulated human T cells: kinetics, mitogen requirements and effects of cyclosporin A. J. Exp. Med. 163:922–937.
   PubMedGoogle Scholar
• Granelli-Piperino, A., and M. Keane. 1988. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood. Transplant. Proc. 20:136–142.
   Google Scholar
• Granelli-Piperino, A., P. Nolan, K. Inaba, and R. M. Steinman. 1990. The effects of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin-2 promoter. J. Exp. Med. 172:1869–1872.
   PubMedGoogle Scholar
• Gunter, K. C., S. G. Irving, P. F. Zipfel, U. Siebenlist, and K. Kelly. 1989. Cyclosporin A-mediated inhibition of mitogen- induced gene transcription is specific for the mitogen stimulus and cell type. J. Immunol. 142:3286–3291.
   PubMed Web of Science ®Google Scholar
• Harding, M. W., A. Galat, D. E. Wehling, and S. L. Schreiber. 1989. A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl-prolyl isomerase. Nature (London) 341:758–760.
   PubMed Web of Science ®Google Scholar
• Herold, K. C., D. W. Lancki, R. L. Moldwin, and F. W. Fitch. 1986. Immunosuppressive effects of cyclosporine A on cloned T cells. J. Immunol. 136:1315–1321.
   PubMedGoogle Scholar
• Hollon, T., and F. K. Yoshimura. 1989. Variation in enzymatic transient gene expression assays. Anal. Biochem. 182:411–418.
   PubMedGoogle Scholar
• Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. Kappa-B-specific DNA binding proteins: role in the regulation of human IL-2 gene expression. Science 244:457–460.
   PubMed Web of Science ®Google Scholar
• Hunninghake, G. W., M. M. Monick, B. Liu, and M. F. Stinski. 1989. The promoter-regulatory region of the major immediate- early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63:3026–3033.
   PubMed Web of Science ®Google Scholar
• Inamura, N., M. Hashimoto, K. Nakahara, H. Aoki, I. Yamaguchi, and M. Kohsaka. 1988. Immunosuppressive effect of FK- 506 on collagen-induced arthritis in rats. Clin. Immunol. Immu- nopathol. 46:82–90.
   PubMedGoogle Scholar
• Irving, S. G., C. H. June, P. F. Zipfel, U. Siebenlist, and K. Kelly. 1989. Mitogen-induced genes are subject to multiple pathways of regulation in the initial stages of T-cell activation. Mol. Cell. Biol. 9:1034–1040.
   PubMedGoogle Scholar
• Isakov, N., M. I. Mally, W. Scholz, and A. Altman. 1987. T-lymphocyte activation: the role of protein kinase C and the bifurcating inositol phospholipid signal transduction pathway. Immunol. Rev. 95:89–111.
   PubMed Web of Science ®Google Scholar
• June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472–4481.
   PubMed Web of Science ®Google Scholar
• Kamps, M. P., L. Corcoran, J. H. LeBowitz, and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10:5464–5472.
   PubMedGoogle Scholar
• Kay, J. E., and C. R. Benzie. 1990. Lymphocyte-T activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. Immunol. Lett. 23:155–159.
   Google Scholar
• Kemler, L., and W. Schaffner. 1990. Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J. 4:1444–1449.
   PubMedGoogle Scholar
• Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and H. Imanaka. 1987. FK-506, a novel immunosuppressant isolated from a Streptomy- ces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 40:1249–1255.
   PubMed Web of Science ®Google Scholar
• Kino, T., H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Yajima, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and T. Ochia. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 40:1256–1265.
   PubMed Web of Science ®Google Scholar
• Kristie, T. M., J. H. LeBowitz, and P. A. Sharp. 1989. The octamer binding proteins form multi-protein-DNA complexes with the HSV aTIF regulatory protein. EMBO J. 8:4229–4238.
   PubMedGoogle Scholar
• Kronke, M., W. J. Leonard, J. Depper, S. Arya, F. Wong-Stahl, R. C. Gallo, T. Waldman, and W. C. Greene. 1984. Cyclosporin A inhibits T-cell growth factor expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 81:5214–5218.
   PubMed Web of Science ®Google Scholar
• Kronke, M., W. J. Leonard, J. M. Depper, and W. C. Greene. 1985. Sequential expression of genes involved in human T-lymphocyte growth and differentiation. J. Exp. Med. 161:1593–1598.
   PubMedGoogle Scholar
• Mattila, P. R., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporine A and FK-506 suggest a novel step in the activation of T-lymphocytes. EMBO J. 9:4425–4433.
   PubMedGoogle Scholar
• Mizushima, Y., H. Kosaka, S. Sakuma, K. Kanda, K. Itoh, T. Osugi, A. Mizushima, T. Hamaoka, H. Yoshida, K. Sobue, and K. Fujiwara. 1987. Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signaling. J. Biochem. 102:1193–1201.
   PubMed Web of Science ®Google Scholar
• Molitor, J., W. Walker, S. Doerre, D. W. Ballard, and W. C. Greene. 1990. NF-ΚB: a family of inducible and differentially expressed enhancer binding proteins in human T cells. Proc. Natl. Acad. Sci. USA 87:10028–10032.
   PubMed Web of Science ®Google Scholar
• Muegge, K., T. M. Williams, J. Kant, M. Karin, R. Chiu, A. Schmidt, U. Siebenlist, H. A. Young, and S. K. Durum. 1989. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 246:249–251.
   PubMed Web of Science ®Google Scholar
• Nabel, G. J., C. Gorka, and D. Baltimore. 1988. T-cell specific expression of interleukin-2: evidence for a negative regulatory site. Proc. Natl. Acad. Sci. USA 85:2934–2938.
   PubMedGoogle Scholar
• Nelsen, B., L. Hellman, and R. Sen. 1988. The NF-κB-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol. Cell. Biol. 8:3526–3531.
   PubMedGoogle Scholar
• Niller, H. H., and L. Hennighausen. 1990. Phytohemagglutinin- induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J. Virol. 64:2388–2391.
   PubMedGoogle Scholar
• Ohlsson, H., and T. Edlund. 1986. Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell 45:35–44.
   PubMedGoogle Scholar
• Rice, G. P., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate early gene products. Proc. Natl. Acad. Sci. USA 81:6134–6138.
   PubMed Web of Science ®Google Scholar
• Sambucetti, L. C., J. M. Cherrington, G. W. Wilkinson, and E. S. Mocarski. 1989. NF-ΚB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251–4258.
   PubMed Web of Science ®Google Scholar
• Sawada, S., G. Suzuki, Y. Kawase, and F. Takaku. 1987. Novel immunosuppressive agent, FK-506, in vitro effects on cloned T-cell activation. J. Immunol. 139:1797–1803.
   PubMed Web of Science ®Google Scholar
• Schmidt, A., L. Hennighausen, and U. Siebenlist. 1990. Inducible nuclear factor binding to the ΚB elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J. Virol. 64:4037–4041.
   PubMed Web of Science ®Google Scholar
• Schreiber, S. L. 1991. Chemistry and biology of the immuno- philins and their immunosuppressive ligands. Science 251:283-287.
   PubMed Web of Science ®Google Scholar
• Serfling, E., R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:465–473.
   PubMed Web of Science ®Google Scholar
• Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T-cell activation genes. Science 241:202–215.
   PubMed Web of Science ®Google Scholar
• Shevach, E. M. 1985. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 3:397–423.
   PubMed Web of Science ®Google Scholar
• Shibuya, H., and T. Taniguchi. 1989. Identification of multiple cis-elements and trans-acting factors involved in the induced expression of the human IL-2 gene. Nucleic Acids Res. 17: 9173–9184.
   PubMedGoogle Scholar
• Shibuya, H., M. Yonegama, and T. Taniguchi. 1984. Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes. Int. J. Immunol. 1:43–49.
   Google Scholar
• Siebenlist, U., D. B. Durand, P. Bressler, N. J. Holbrook. C. A. Norris, M. Kamoun, J. A. Kant, and G. R. Crabtree. 1986. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol. Cell. Biol. 6:3042–3049.
   PubMedGoogle Scholar
• Siekierka, J. J., S. H. Hung, M. Poe, C. S. Lin, and N. H. Sigal. 1989. A cytosolic binding protein for the immunosuppressant FK-506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (London) 341:755–757.
   PubMed Web of Science ®Google Scholar
• Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (London) 319:154–158.
   PubMed Web of Science ®Google Scholar
• Starzl, T. E., S. Todo, J. Fung, A. J. Demetris, R. Venkataramman, and A. Jain. 1989. FK-506 for liver, kidney, and pancreas transplantation. Lancet ii:1000–1004.
   Google Scholar
• Strauss, F., and A. Varshavsky. 1984. A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome. Cell 37:889–901.
   PubMed Web of Science ®Google Scholar
• Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature (London) 337:473–475.
   PubMed Web of Science ®Google Scholar
• Tocci, M., and F. Dumont. Unpublished observations.
   Google Scholar
• Tocci, M. J., D. A. Matkovich, K. A. Collier, P. Kwok, F. Dumont, C. S. Lin, S. DeGudicibus, J. J. Siekierka, J. Chin, and N. I. Hutchinson. 1989. The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143:718–726.
   PubMed Web of Science ®Google Scholar
• Todo, S., Y. Ueda, J. A. Demeris, O. Inventarza, M. Nalesnik, R. Venkataranan, L. Makowka, and T. E. Starzl. 1988. Immunosuppression of canine, monkey and baboon allografts by FK- 506: with special reference to synergism with other drugs and tolerance induction. Surgery 104:239–249.
   PubMed Web of Science ®Google Scholar
• Vacca, A., S. Martinotti, I. Screpanti, M. Maroder, M. P. Felli, A. R. Farina, A. Gismondi, A. Santoni, L. Frati, and A. Gulino. 1990. Transcriptional regulation of the interleukin-2 gene by glucocorticoid hormones. Role of steroid receptor and antigen- responsive 5′-flanking sequences. J. Biol. Chem. 265:8075-8080.
   Google Scholar
• Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol. 133:123–128.
   PubMed Web of Science ®Google Scholar
• White, D. J. G., and R. Y. Calne. 1982. The use of cyclosporin A: immunosuppression in organ grafting. Immunol. Rev. 65: 115–131.
   PubMed Web of Science ®Google Scholar
• Wiederrecht, G., L. Brizuela, K. Elliston, N. H. Sigal, and J. J. Siekierka. 1991. FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophillins. Proc. Natl. Acad. Sci. USA 88:1029–1033.
   PubMedGoogle Scholar
• Williams, T. M., L. Eisenberg, J. E. Burlein, C. A. Norris, S. Pancer, D. Yao, S. Burger, M. Kamoun, and J. A. Kant. 1988. Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression. J. Immunol. 141:662–666.
   PubMed Web of Science ®Google Scholar
• Wiskocil, R., A. Weiss, J. Imboden, R. Kamin-Lewis, and J. Stobo. 1985. Activation of a human T-cell line: a two stimulus requirement in the pre-translational events involved in the coordinate expression of interleukin-2 and -γ-interferon genes. J. Immunol. 134:1599–1603.
   PubMedGoogle Scholar